Reporte zur Charge 007NL20A

Symptomtext

Sensitivity; Pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE HYPERSENSITIVITY (Sensitivity) and VACCINATION SITE PAIN (Pain) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007NL20A) for COVID-19 vaccination. The patient's past medical history was not reported . On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE HYPERSENSITIVITY (Sensitivity) and VACCINATION SITE PAIN (Pain). At the time of the report, VACCINATION SITE HYPERSENSITIVITY (Sensitivity) and VACCINATION SITE PAIN (Pain) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No Concomitant medications were provided Treatment information include Ice Pack This case was linked to MOD-2021-031381, MOD-2021-142201 (Patient Link).